XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjects.

@article{Gu2015XRCC1GP,
  title={XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjects.},
  author={Ai-qin Gu and Wei-ming Wang and Wen-Yi Chen and Chun-lei Shi and Jian-Hong Lu and Jun-qing Han},
  journal={International journal of clinical and experimental medicine},
  year={2015},
  volume={8 1},
  pages={145-54}
}
OBJECTIVE To evaluate the correlation between genetic polymorphisms in x-ray repair cross complementing group 1 (XRCC1) and sensitivity to platinum-based chemotherapy drugs in patients with non-small cell lung cancer. METHODS Reports published before June 2014 were retrieved from the following databases: China Biology Medicine (CBM), China Academic Journal Full-Text Database (CNKI), China Science and Technology Journal Full-Text Database (VIP), Wanfang Data, PubMed and Excerpta Medica… CONTINUE READING
Highly Cited
This paper has 19 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 45 references

Spanish Lung Cancer Group. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine- XRCC1 polymorphism and chemotherapy of NSCLC

  • R de las Peñas, M Sanchez-Ronco, +14 authors R Rosell
  • Int J Clin Exp Med
  • 2015
1 Excerpt

Effects of polymorphisms in the XRCC 1 , XRCC 3 , and XPG genes on clinical outcomes of platinum - based chemotherapy for treatment of non - small cell lung cancer

  • D Liu, J Wu, GY Shi, HF Zhou, Y Yu
  • Genet Mol Res
  • 2014

Similar Papers

Loading similar papers…